𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical and pathological effects of the magnetic resonance imaging contrast agent gadodiamide on a new, adenine-sensitized, rat model of nephrogenic systemic fibrosis

✍ Scribed by N. Fretellier; N. Bouzian; P. Bruneval; F. Daubine; N. Parmentier; J. Idee; C. Corot

Book ID
116924441
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
83 KB
Volume
205
Category
Article
ISSN
0378-4274

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A new gadolinium-based contrast agent fo
A new gadolinium-based contrast agent for magnetic resonance imaging of brain tumors: Kinetic study on a C6 rat glioma model
✍ Emmanuel Fonchy; Hana Lahrech; Anne François-Joubert; Roger Dupeyre; Soraya Bend 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 2 views

## Abstract T~1~‐weighted magnetic resonance imaging (MRI) was used to evaluate the potential interest of a new Gd‐based contrast agent, termed P760, to characterize brain tumor heterogeneity and vascularization and to delineate regions containing permeable vessels. The C6 rat glioma model was used

Retrospective assessment of prevalence o
Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patients
✍ Hani H. Abujudeh; Hillary Rolls; Rathachai Kaewlai; Sheela Agarwal; Zelalem A. G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract From May 2007 to January 2008, patients with Stage 3‐5 chronic kidney disease (CKD) undergoing gadobenate dimeglumine (GBD)‐enhanced magnetic resonance (MR) examinations were included in the retrospective investigation. The electronic medical records were reviewed to assess the prevalen